PTNS on Urinary and Global Quality of Life in MS Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

23 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-27

Study Completion Date

2022-11-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-centered, prospective, longitudinal, observational cohort study of patients with MS who suffer from lower urinary tract symptoms (LUTS) and are refractory to two prior treatment modalities who have elected to pursue PTNS therapy for LUTS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of TTNS on Bladder Symptoms Among People With MS, A RCT

NCT06341673

Overactive Bladder Syndrome

RECRUITING NA

Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.

NCT04573673

Multiple Sclerosis Lower Urinary Tract Symptoms

RECRUITING NA

Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.

NCT06143397

Multiple Sclerosis Overactive Bladder Syndrome

COMPLETED NA

Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Multiple Sclerosis Related Urge Incontinence

NCT06314412

Multiple Sclerosis

RECRUITING NA

Stress Urinary Incontinence in Women With Multiple Sclerosis

NCT03332654

Urinary Incontinence, Stress Multiple Sclerosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Lower Urinary Tract Symptoms Neurogenic Bladder Overactive Bladder Urinary Incontinence Urinary Urge Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Multiple Sclerosis
* Lower urinary tract symptoms (urinary frequency, urgency and/or incontinence)
* Failed prior first and second line therapy (behavioral and pharmacotherapy)
* Electing for Posterior Tibial Nerve Stimulation therapy for urinary symptoms
* Patients performing Intermittent Catheterization are Eligible

Exclusion Criteria

* Indwelling catheters (urethral or suprapubic)
* Currently pregnant or planning pregnancy
* Unable to attend weekly office visits for PTNS
* Urodynamic findings of bladder outlet obstruction

History of:

bladder reconstruction (augmentation cystoplasty, catheterizable channel) cystectomy bladder stones pacemaker or defibrillator malignancy of bladder sacral neuromodulation intravesical injection of onabotulinum toxin within 9 months

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No